Attached files
| file | filename |
|---|---|
| 8-K - 8-K - NATIONAL INSTRUMENTS CORP | a20207308-kq2earningsr.htm |
EXHIBIT 99.1
Contact: Marissa Vidaurri
Head of Investor Relations
(512) 683-5215
NI Reports Second Quarter Revenue of $301 Million
Company to host virtual investor conference August 4
Q2 2020 Summary
• | Revenue of $301 million, down 10 percent year over year and down 8 percent year over year on an organic basis |
• | GAAP gross margin of 71 percent |
• | Non-GAAP gross margin of 74 percent |
• | Fully diluted GAAP EPS of $0.08 and fully diluted non-GAAP EPS of $0.26 |
• | GAAP net income of $11 million and non-GAAP net income of $34 million |
• | EBITDA of $33 million for second quarter |
• | Cash and short-term investments of $608 million as of June 30, 2020, a significant portion of which was used to fund the OptimalPlus acquisition on July 2, 2020 |
H1 2020 Summary
• | Revenue of $611 million, down 5 percent, and down 3 percent on an organic basis, as compared to the first six months of 2019 |
• | GAAP net income of $144 million, which includes $123 million gain, net of tax, related to AWR divestment |
• | Non-GAAP net income of $68 million |
AUSTIN, Texas - Jul. 30, 2020 - National Instruments (Nasdaq: NATI) today announced Q2 2020 revenue of $301 million, down 10 percent year over year and down 3 percent sequentially. Organic revenue, which we define as GAAP revenue excluding the impact of acquisitions and divestitures completed within the past twelve months, declined 8 percent year over year.
In Q2 2020 the value of the company's organic orders, which we define as the value of the company's orders excluding the impact of acquisitions and divestitures noted above, was down 6 percent year over year; organic orders over $20,000 were up 4 percent year over year; and organic orders under $20,000 were down 21 percent year over year. For Q2, on an organic order basis, the Americas region had year over year order growth of 1 percent, EMEA orders were down 23 percent, and in APAC orders were flat during the quarter. We previously included order value and net sales attributable to our operations in India within the EMEA region. In the second quarter of 2020, we began including these amounts within the APAC geographic region, to reflect recent changes within our organizational structure. India represents approximately 2 percent of our total orders.
Geographic revenue in U.S. dollar terms for Q2 2020 compared with Q2 2019 was down 6 percent in the Americas, down 7 percent in APAC and down 19 percent in EMEA. Excluding the impact of foreign currency exchange, revenue was down 5 percent in the Americas, down 4 percent in APAC and down 17 percent in EMEA. Historical revenue from these three regions can be found on NI’s investor website at www.ni.com/nati.
In Q2, GAAP gross margin was 71 percent and non-GAAP gross margin was 74 percent. Total GAAP operating expenses were $199 million, down 9 percent year over year. Total non-GAAP operating expenses were down 11 percent year over year at $181 million. GAAP operating margin was 5 percent in Q2, with GAAP operating income of $16 million. Non-GAAP operating margin was 14 percent in Q2, with non-GAAP operating income of $44 million.
GAAP net income for Q2 was $11 million, with fully diluted earnings per share (EPS) of $0.08, and non-GAAP net income was $34 million, with non-GAAP fully diluted EPS of $0.26, at the midpoint of our guidance. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $33 million for Q2.
For the first half of 2020, revenue was $611 million, down 5 percent year over year and on an organic basis, revenue was down 3 percent year over year. The value of the company's first half 2020 total organic orders was also down 3 percent year over year.
"I am proud of the ability of our employees to adapt as the COVID-19 pandemic continues globally. We delivered results within expectations shared June 9, 2020 and our operational continuity ensured we were able to meet customer demand," said Eric Starkloff, NI CEO. "The core strengths of NI are clear - our broad customer base, diversity of business, and the value our customers see in our software-connected systems. I believe we are in a stronger position strategically as compared to past industrial recessions with a focus on the parts of the market where our customers continue to invest."
"Although economic uncertainty remains, I am confident in our strategy and ability to maintain stability in the short-term while staying focused on our long-term growth ambitions," said Karen Rapp, NI CFO. "We will continue to be diligent in managing expenses through the second half of 2020. We believe our strong balance sheet and cash position provides us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value."
As of June 30, 2020, NI had $608 million in cash and short-term investments. During the second quarter of 2020, NI amended and restated its credit agreement to provide for an initial credit facility of $145 million, with the potential to request, subject to the terms and conditions of the credit agreement, including obtaining commitments from existing lenders or new lenders, additional term loan or revolving commitments of up to $105 million in the aggregate. During the second quarter, NI paid $34 million in dividends and repurchased approximately 500,000 shares of our common stock at an average price of $34.08 per share. The NI Board of Directors approved a quarterly dividend of $0.26 per share payable on September 8, 2020, to stockholders of record on August 17, 2020.
The company’s non-GAAP results exclude, as applicable, the impact of purchase accounting adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.
Guidance
NI currently expects Q3 GAAP revenue to be in the range of $283 million to $323 million and Q3 non-GAAP revenue, which adjusts for the impact of purchase price accounting related to OptimalPlus, to be in the range of $285 million to $325 million. The company currently expects that GAAP fully diluted EPS will be in the range of -$0.09 to $0.05 for Q3, with non-GAAP fully diluted EPS expected to be in the range of $0.14 to $0.28.
Virtual NATI Investor Conference
The NI leadership team will host a "virtual" investor conference on Tuesday, August 4 at 9:00 a.m. Attendees will hear more about our long-term strategy for growth, value of our software-connected systems, industry focus, and our financial model. To register, please visit ni.com/nati.
Conference Call Information
Interested parties can listen to the Q2 2020 earnings conference call with NI management today, July 30, at 4:00 p.m. CT at ni.com/call or by dialing 855-212-2361 and entering confirmation code 3473967 ten minutes prior to the call start time. Replay information is available by calling (855) 859-2056 and entering confirmation code 3473967, shortly after the call through August 2 at 10:00 p.m. CT or by visiting the company’s website at ni.com/call.
Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its revenue, gross profit, gross margin, operating expenses, operating income, operating margin, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three and six months ended June 30, 2020 and 2019, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP fully diluted EPS.
When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company’s operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider purchase accounting adjustments, stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods; to establish operational goals; to compare with its business plan and individual operating budgets; to measure management performance for the purposes of executive compensation, including payments to be made under bonus plans; to assist the public in measuring the company’s performance relative to the company’s long-term public performance goals; to allocate resources; and, relative to the company’s historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.
This news release discloses the company’s EBITDA for the three and six months ended June 30, 2020 and 2019. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this news release. This news release also discloses the year-over-year change in the company's organic revenue for the three and six months ended June 30, 2020. The company believes that including its year-over-year change in organic revenue assists investors in assessing the company's operational performance. A reconciliation of its year-over-year change in organic revenue to its year-over-year change in GAAP revenue is included with this news release.
Forward-Looking Statements
This release contains "forward-looking statements" including statements regarding compared to the 2009 economic downturn, I believe we are in a stronger position strategically as compared to past industrial recessions with a focus on the parts of the market where our customers continue to invest; although economic uncertainty remains, I am confident in our strategy and ability to maintain stability in the short-term while staying focused on our long-term growth ambitions; we will continue to be diligent in managing expenses through the second half of 2020; we believe our strong balance sheet and cash position provides us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value; expecting Q3 GAAP revenue to be in the range of $283 million to $323 million, expecting Q3 non-GAAP revenue to be in the range of $285 million to $325 million, and expecting that GAAP fully diluted EPS will be in the range of -$0.09 to $0.05 for Q3, with non-GAAP fully diluted EPS expected to be in the range of $0.14 to $0.28; and guidance regarding Q3 organic (non-GAAP) revenue. These statements are subject to a number of risks and uncertainties, including risks and uncertainties related to the COVID-19 virus and further economic and market disruptions resulting from COVID-19; further adverse changes or fluctuations in the global economy; further adverse fluctuations in our industry; foreign exchange fluctuations; changes in the current global trade regulatory environment; fluctuations in customer demands and markets; fluctuations in demand for NI products including orders from NI’s large customers; component shortages; delays in the release of new products; NI’s ability to effectively manage its operating expenses; manufacturing inefficiencies and the level of capacity utilization; the impact of any recent or future acquisitions or divestitures by NI (including
the ability to successfully operate or integrate the acquired company’s business into NI, the ability to retain and integrate the acquired company’s employees into NI, and the ability to realize the expected benefits of the acquisition); expense overruns; and adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the year ended Dec. 31, 2019, its Form 10-Q for the quarter ended March 31, 2020 and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.
All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.
About NI
At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day. (NATI-F)]
LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
National Instruments | |||||||||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||||||||||
(in thousands) | |||||||||||||||||||
June 30, | December 31, | ||||||||||||||||||
2020 | 2019 | ||||||||||||||||||
(unaudited) | |||||||||||||||||||
Assets | |||||||||||||||||||
Current assets: | |||||||||||||||||||
Cash and cash equivalents | $ | 471,205 | $ | 194,616 | |||||||||||||||
Short-term investments | 137,104 | 237,983 | |||||||||||||||||
Accounts receivable, net | 211,766 | 248,872 | |||||||||||||||||
Inventories, net | 209,928 | 200,410 | |||||||||||||||||
Prepaid expenses and other current assets | 65,817 | 65,477 | |||||||||||||||||
Total current assets | 1,095,820 | 947,358 | |||||||||||||||||
Property and equipment, net | 247,548 | 243,717 | |||||||||||||||||
Goodwill | 255,153 | 262,242 | |||||||||||||||||
Intangible assets, net | 68,975 | 84,083 | |||||||||||||||||
Operating lease right-of-use assets | 63,895 | 70,407 | |||||||||||||||||
Restricted cash | 70,000 | - | |||||||||||||||||
Other long-term assets | 48,424 | 44,082 | |||||||||||||||||
Total assets | $ | 1,849,815 | $ | 1,651,889 | |||||||||||||||
Liabilities and Stockholders' Equity | |||||||||||||||||||
Current liabilities: | |||||||||||||||||||
Accounts payable and accrued expenses | $ | 53,247 | $ | 52,192 | |||||||||||||||
Accrued compensation | 44,431 | 47,732 | |||||||||||||||||
Deferred revenue - current | 113,785 | 131,445 | |||||||||||||||||
Operating lease liabilities - current | 13,583 | 13,431 | |||||||||||||||||
Other taxes payable | 39,477 | 40,607 | |||||||||||||||||
Debt, current | 3,500 | - | |||||||||||||||||
Other current liabilities | 66,818 | 20,716 | |||||||||||||||||
Total current liabilities | 334,841 | 306,123 | |||||||||||||||||
Deferred income taxes | 16,258 | 14,065 | |||||||||||||||||
Liability for uncertain tax positions | 6,808 | 6,652 | |||||||||||||||||
Income tax payable - non-current | 61,628 | 69,151 | |||||||||||||||||
Deferred revenue - non-current | 32,468 | 33,480 | |||||||||||||||||
Operating lease liabilities - non-current | 34,655 | 40,650 | |||||||||||||||||
Debt, noncurrent | 85,020 | - | |||||||||||||||||
Other long-term liabilities | 8,498 | 5,418 | |||||||||||||||||
Total liabilities | $ | 580,176 | $ | 475,539 | |||||||||||||||
Stockholders' equity: | |||||||||||||||||||
Common stock | 1,314 | 1,305 | |||||||||||||||||
Additional paid-in capital | 993,058 | 953,578 | |||||||||||||||||
Retained earnings | 299,132 | 242,537 | |||||||||||||||||
Accumulated other comprehensive loss | (23,865) | (21,070) | |||||||||||||||||
Total stockholders' equity | 1,269,639 | 1,176,350 | |||||||||||||||||
Total liabilities and stockholders' equity | $ | 1,849,815 | $ | 1,651,889 | |||||||||||||||
National Instruments | ||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||
(in thousands, except per share data, unaudited) | ||||||||||||
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||
Net sales: | ||||||||||||
Product | $ | 266,261 | $ | 299,798 | $ | 540,239 | $ | 577,500 | ||||
Software maintenance | 35,068 | 34,433 | 70,470 | 67,805 | ||||||||
Total net sales | 301,329 | 334,231 | 610,709 | 645,305 | ||||||||
Cost of sales: | ||||||||||||
Product | 83,795 | 81,741 | 165,866 | 155,929 | ||||||||
Software maintenance | 2,106 | 2,025 | 3,796 | 3,912 | ||||||||
Total cost of sales | 85,901 | 83,766 | 169,662 | 159,841 | ||||||||
Gross profit | 215,428 | 250,465 | 441,047 | 485,464 | ||||||||
71.5% | 74.9% | 72.2% | 75.2% | |||||||||
Operating expenses: | ||||||||||||
Sales and marketing | 105,419 | 120,868 | 221,165 | 238,419 | ||||||||
Research and development | 64,225 | 68,257 | 135,846 | 134,423 | ||||||||
General and administrative | 29,369 | 29,044 | 55,549 | 56,927 | ||||||||
Total operating expenses | 199,013 | 218,169 | 412,560 | 429,769 | ||||||||
Gain on sale of business | - | - | 159,753 | - | ||||||||
Operating income | 16,415 | 32,296 | 188,240 | 55,695 | ||||||||
Other income (expense): | (1,143) | 555 | (583) | 3,131 | ||||||||
Income before income taxes | 15,272 | 32,851 | 187,657 | 58,826 | ||||||||
Provision for income taxes | 4,383 | 4,159 | 44,113 | 6,914 | ||||||||
Net income | $ | 10,889 | $ | 28,692 | $ | 143,544 | $ | 51,912 | ||||
Basic earnings per share | $ | 0.08 | $ | 0.22 | $ | 1.10 | $ | 0.39 | ||||
Diluted earnings per share | $ | 0.08 | $ | 0.22 | $ | 1.09 | $ | 0.39 | ||||
Weighted average shares outstanding - | ||||||||||||
Basic | 131,014 | 132,062 | 130,813 | 132,156 | ||||||||
Diluted | 131,602 | 132,973 | 131,499 | 133,172 | ||||||||
Dividends declared per share | $ | 0.26 | $ | 0.25 | $ | 0.52 | $ | 0.50 | ||||
Condensed Consolidated Statements of Cash Flows | ||||||
(in thousands, unaudited) | ||||||
Six Months Ended June 30, | ||||||
2020 | 2019 | |||||
Cash flow from operating activities: | ||||||
Net income | $ | 143,544 | 51,912 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Disposal gain on sale of business | (159,753) | - | ||||
Depreciation and amortization | 38,341 | 35,984 | ||||
Stock-based compensation | 27,335 | 24,662 | ||||
Deferred income taxes | 2,711 | 2,268 | ||||
Net change in operating assets and liabilities | 49,320 | (26,189) | ||||
Net cash provided by operating activities | 101,498 | 88,637 | ||||
Cash flow from investing activities: | ||||||
Capital expenditures | (25,362) | (26,048) | ||||
Proceeds from sale of business, net of cash divested | 160,266 | - | ||||
Capitalization of internally developed software | (3,108) | (4,497) | ||||
Additions to other intangibles | (630) | (487) | ||||
Acquisitions of equity-method investments | - | (9,784) | ||||
Purchases of short-term investments | (206,330) | (91,777) | ||||
Sales and maturities of short-term investments | 306,955 | 117,108 | ||||
Net cash provided by (used by) investing activities | 231,791 | (15,485) | ||||
Cash flow from financing activities: | ||||||
Proceeds from revolving loan facility | 20,000 | - | ||||
Proceeds from term loan | 70,000 | - | ||||
Debt issuance costs | (1,480) | - | ||||
Proceeds from issuance of common stock | 17,252 | 17,645 | ||||
Repurchase of common stock | (23,680) | (92,375) | ||||
Dividends paid | (68,156) | (66,067) | ||||
Net cash provided by (used by) financing activities | 13,936 | (140,797) | ||||
Impact of changes in exchange rates on cash | (636) | 20 | ||||
Net change in cash, cash equivalents and restricted cash | 346,589 | (67,625) | ||||
Cash, cash equivalents and restricted cash at beginning of period | 194,616 | 259,386 | ||||
Cash, cash equivalents and restricted cash at end of period | $ | 541,205 | 191,761 | |||
The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction costs, capitalization and amortization of internally developed software costs, restructuring charges and gain on sale of business that were recorded in the line items indicated below (unaudited) (in thousands) | ||||||||||||
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||
Stock-based compensation | ||||||||||||
Cost of sales | $ | 932 | $ | 890 | $ | 1,736 | $ | 1,683 | ||||
Sales and marketing | 6,467 | 5,140 | 11,642 | 9,515 | ||||||||
Research and development | 4,428 | 4,379 | 7,947 | 7,929 | ||||||||
General and administrative | 3,404 | 3,219 | 6,008 | 5,535 | ||||||||
Provision for income taxes | (2,905) | (3,940) | (4,406) | (5,776) | ||||||||
Total | $ | 12,326 | 9,688 | 22,927 | 18,886 | |||||||
Amortization of acquisition intangibles | ||||||||||||
Cost of sales | $ | 635 | $ | 841 | $ | 1,381 | $ | 1,692 | ||||
Sales and marketing | 480 | 494 | 966 | 993 | ||||||||
Research and development | 28 | 28 | 55 | 56 | ||||||||
Other expense (income) | 117 | 162 | 241 | 162 | ||||||||
Provision for income taxes | (133) | (192) | (290) | (386) | ||||||||
Total | $ | 1,127 | $ | 1,333 | $ | 2,353 | $ | 2,517 | ||||
Acquisition transaction costs, restructuring charges, and other | ||||||||||||
Cost of sales | $ | - | $ | - | $ | 20 | $ | - | ||||
Sales and marketing | 1,239 | 3,153 | 7,612 | 5,296 | ||||||||
Research and development | 147 | 311 | 4,816 | 656 | ||||||||
General and administrative | 3,399 | 616 | 2,385 | 1,528 | ||||||||
Gain on sale of business(1) | - | - | (159,753) | - | ||||||||
Other expense (income) | - | - | 128 | - | ||||||||
Provision for income taxes | (78) | (1,010) | 34,676 | (1,850) | ||||||||
Total | $ | 4,707 | $ | 3,070 | $ | (110,116) | $ | 5,630 | ||||
(1): During the first quarter of 2020, the company recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business". | ||||||||||||
Capitalization and amortization of internally developed software costs | ||||||||||||
Cost of sales | $ | 7,144 | $ | 6,537 | $ | 14,226 | $ | 13,119 | ||||
Research and development | (1,181) | (2,218) | (3,095) | (4,497) | ||||||||
Provision for income taxes | (1,252) | (907) | (2,337) | (1,811) | ||||||||
Total | $ | 4,711 | $ | 3,412 | $ | 8,794 | $ | 6,811 | ||||
National Instruments | ||||||||||||||
Reconciliation of GAAP to Non-GAAP Measures | ||||||||||||||
(in thousands, unaudited) | ||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||
June 30, | June 30, | |||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit | ||||||||||||||
Gross profit, as reported | $ | 215,428 | $ | 250,465 | $ | 441,047 | $ | 485,464 | ||||||
Stock-based compensation | 932 | 890 | 1,736 | 1,683 | ||||||||||
Amortization of acquisition intangibles | 635 | 841 | 1,381 | 1,692 | ||||||||||
Acquisition transaction costs, restructuring charges and other | - | - | 20 | - | ||||||||||
Amortization of internally developed software costs | 7,144 | 6,537 | 14,226 | 13,119 | ||||||||||
Non-GAAP gross profit | $ | 224,139 | $ | 258,733 | $ | 458,410 | $ | 501,958 | ||||||
Non-GAAP gross margin | 74.4% | 77.4% | 75.1% | 77.8% | ||||||||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses | ||||||||||||||
Operating expenses, as reported | $ | 199,013 | $ | 218,169 | $ | 412,560 | $ | 429,769 | ||||||
Stock-based compensation | (14,299) | (12,738) | (25,597) | (22,979) | ||||||||||
Amortization of acquisition intangibles | (508) | (522) | (1,021) | (1,049) | ||||||||||
Acquisition transaction costs, restructuring charges and other | (4,785) | (4,080) | (14,813) | (7,480) | ||||||||||
Capitalization of internally developed software costs | 1,181 | 2,218 | 3,095 | 4,497 | ||||||||||
Non-GAAP operating expenses | $ | 180,602 | $ | 203,047 | $ | 374,224 | $ | 402,758 | ||||||
Reconciliation of Operating Income to Non-GAAP Operating Income | ||||||||||||||
Operating income, as reported | $ | 16,415 | $ | 32,296 | $ | 188,240 | $ | 55,695 | ||||||
Stock-based compensation | 15,231 | 13,628 | 27,333 | 24,662 | ||||||||||
Amortization of acquisition intangibles | 1,143 | 1,363 | 2,402 | 2,741 | ||||||||||
Acquisition transaction costs, restructuring charges and other | 4,785 | 4,080 | 14,833 | 7,480 | ||||||||||
Net amortization of internally developed software costs | 5,963 | 4,319 | 11,131 | 8,622 | ||||||||||
Gain on sale of business(1) | - | - | (159,753) | - | ||||||||||
Non-GAAP operating income | $ | 43,537 | $ | 55,686 | $ | 84,186 | $ | 99,200 | ||||||
Non-GAAP operating margin | 14.4% | 16.7% | 13.8% | 15.4% | ||||||||||
Reconciliation of Income before income taxes to Non-GAAP Income before income taxes | ||||||||||||||
Income before income taxes, as reported | $ | 15,272 | $ | 32,851 | $ | 187,657 | $ | 58,826 | ||||||
Stock-based compensation | 15,231 | 13,628 | 27,333 | 24,662 | ||||||||||
Amortization of acquisition intangibles | 1,260 | 1,525 | 2,643 | 2,903 | ||||||||||
Acquisition transaction costs, restructuring charges and other | 4,785 | 4,080 | 14,961 | 7,480 | ||||||||||
Net amortization of internally developed software costs | 5,963 | 4,319 | 11,131 | 8,622 | ||||||||||
Gain on sale of business(1) | - | - | (159,753) | - | ||||||||||
Non-GAAP income before income taxes | $ | 42,511 | $ | 56,403 | $ | 83,972 | $ | 102,493 | ||||||
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes | ||||||||||||||
Provision for income taxes, as reported | $ | 4,383 | $ | 4,159 | $ | 44,113 | $ | 6,914 | ||||||
Stock-based compensation | 2,905 | 3,940 | 4,406 | 5,776 | ||||||||||
Amortization of acquisition intangibles | 133 | 192 | 290 | 386 | ||||||||||
Acquisition transaction costs, restructuring charges and other | 466 | 1,010 | 2,083 | 1,850 | ||||||||||
Net amortization of internally developed software costs | 1,252 | 907 | 2,337 | 1,811 | ||||||||||
Gain on sale of business(1) | (388) | - | (36,759) | - | ||||||||||
Non-GAAP provision for income taxes | $ | 8,751 | $ | 10,208 | $ | 16,470 | $ | 16,737 | ||||||
(1): During the first quarter of 2020, the company recognized a gain of approximately $160 million related to the divestiture of AWR, presented within "Gain on sale of business". | ||||||||||||||
Reconciliation of GAAP Net Income, Diluted EPS, and Revenue to Non-GAAP Net Income, Non-GAAP Diluted EPS, EBITDA, and Organic Revenue (Non-GAAP) |
(in thousands, except per share data, unaudited) |
Three Months Ended | Six Months Ended | |||||||
June 30, | June 30, | |||||||
2020 | 2019 | 2020 | 2019 | |||||
Net income, as reported | $ | 10,889 | $ | 28,692 | $ | 143,544 | $ | 51,912 |
Adjustments to reconcile net income to non-GAAP net income: | ||||||||
Stock-based compensation, net of tax effect | 12,326 | 9,688 | 22,927 | 18,886 | ||||
Amortization of acquisition intangibles, net of tax effect | 1,127 | 1,333 | 2,353 | 2,517 | ||||
Acquisition transaction costs, restructuring charges and other, net of tax effect | 4,319 | 3,070 | 12,878 | 5,630 | ||||
Net amortization of internally developed software costs, net of tax effect | 4,711 | 3,412 | 8,794 | 6,811 | ||||
Gain on sale of business(1), net of tax effect | 388 | 0 | (122,994) | 0 | ||||
Non-GAAP net income | $ | 33,760 | $ | 46,195 | $ | 67,502 | $ | 85,756 |
Non-GAAP net margin | 11.2% | 13.8% | 11.1% | 13.3% | ||||
Diluted EPS, as reported | $ | 0.08 | $ | 0.22 | $ | 1.09 | $ | 0.39 |
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS | ||||||||
Impact of stock-based compensation, net of tax effect | 0.09 | 0.07 | 0.17 | 0.14 | ||||
Impact of amortization of acquisition intangibles, net of tax effect | 0.01 | 0.01 | 0.02 | 0.02 | ||||
Impact of acquisition transaction costs and restructuring charges, net of tax effect | 0.04 | 0.02 | 0.10 | 0.04 | ||||
Impact of net amortization of internally developed software costs, net of tax effect | 0.04 | 0.03 | 0.07 | 0.05 | ||||
Impact of gain on sale of business(1), net of tax effect | - | - | (0.94) | - | ||||
Non-GAAP diluted EPS | $ | 0.26 | $ | 0.35 | $ | 0.51 | $ | 0.64 |
(1): During the first quarter of 2020, the company recognized a gain of approximately $160 million related to the divestiture of AWR, presented within "Gain on sale of business". | ||||||||
Weighted average shares outstanding - Diluted | 131,602 | 132,973 | 131,499 | 133,172 | ||||
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||
Net income, as reported | $ | 10,889 | $ | 28,692 | $ | 143,544 | $ | 51,912 | ||||
Adjustments to reconcile net income to EBITDA: | ||||||||||||
Interest income, net | (945) | (2,012) | (3,168) | (4,232) | ||||||||
Tax expense | 4,383 | 4,159 | 44,113 | 6,914 | ||||||||
Depreciation and amortization | 19,076 | 17,972 | 38,341 | 35,984 | ||||||||
EBITDA | $ | 33,403 | $ | 48,811 | $ | 222,830 | $ | 90,578 | ||||
Weighted average shares outstanding - Diluted | 131,602 | 132,973 | 131,499 | 133,172 | ||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
June 30, | June 30, | |||||||||||||||||||
2020 | 2019 | Percent Inc/(Dec) | 2020 | 2019 | Percent Inc/(Dec) | |||||||||||||||
GAAP Revenue | 301,329 | 334,231 | (10)% | 610,709 | 645,305 | (5)% | ||||||||||||||
less: Net sales from acquisitions or divestitures closed within the last twelve months | - | (7,961) | (1,337) | (15,562) | ||||||||||||||||
Organic Revenue (non-GAAP) | 301,329 | 326,270 | (8)% | 609,372 | 629,743 | (3)% | ||||||||||||||
Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance | ||||||
(unaudited) | ||||||
Three Months Ended | ||||||
September 30, 2020 | ||||||
Low | High | |||||
GAAP Diluted EPS, guidance | $ | (0.09) | $ | 0.05 | ||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS: | ||||||
Impact of stock-based compensation, net of tax effect | 0.09 | 0.09 | ||||
Impact of amortization of acquisition intangibles and deferred revenue purchase accounting adjustments(1), net of tax effect | 0.05 | 0.05 | ||||
Impact of acquisition transaction and integration costs, restructuring charges, and other, net of tax effect | 0.06 | 0.06 | ||||
Impact of net amortization of software development costs, net of tax effect | 0.03 | 0.03 | ||||
Non-GAAP Diluted EPS, guidance | $ | 0.14 | $ | 0.28 | ||
(1): The Company has not yet completed its preliminary purchase price allocation of certain acquired intangible assets and deferred revenue related to the OptimalPlus transaction. The amounts provided in the table above reflect the current best estimate based on a range of assumptions. | ||||||
Reconciliation of GAAP Revenue to Non-GAAP Revenue and Organic Revenue (Non-GAAP), Guidance | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
September 30, | ||||||||
2020 | 2019 | Percent Inc/(Dec) | ||||||
(midpoint) | ||||||||
GAAP Revenue, guidance | $ | 303,000 | $ | 340,442 | (11)% | |||
plus: Impact of purchase accounting adjustments(1) | 2,000 | 0 | ||||||
Non-GAAP Revenue, guidance | $ | 305,000 | $ | 340,442 | (10)% | |||
less: Net sales from acquisitions closed within the last twelve months | (4,000) | - | ||||||
less: Net sales from divestitures closed within the last twelve months | - | (7,833) | ||||||
Organic Revenue (Non-GAAP), guidance | $ | 301,000 | $ | 332,609 | (10)% | |||
(1): The Company has not yet completed its preliminary purchase price allocation of certain acquired intangible assets and deferred revenue related to the OptimalPlus transaction. The amounts provided in the table above reflect the current best estimate based on a range of assumptions. | ||||||||